NASDAQ$ZJYL
Jin Medical International Lt · Q2 2024 earnings
Q2 2024 earnings · · Investor relations
Briefing
ZJYL Q2 2024 — extraction skipped
Jin Medical International Lt filed Form 6-K (accession 0001013762-24-001595) for Q2 2024, but headline financial numerics could not be extracted automatically: no headline numerics found by parser nor by Financial Datasets fallback. The row is marked as AI-processed so the queue advances; numerics will be filled by Financial Datasets on its next pass.
- Form 6-K filed; press release body not parseable here.
- Reason: no headline numerics found by parser nor by Financial Datasets fallback.
- Numerics rely on the Financial Datasets fallback.
Headline financials
Revenue & EPS history
Jin Medical · Revenue · Quarterly
$10.6M
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 8 quarterly earnings reports · overlaid with Q2 2024
-8.9%
Avg return
Earnings day
-3.1%
Avg return
5 days after
+12.7%
Avg return
30 days after
0%
0 / 8 earnings
Positive
+0.0%
Q3 2026
Best reaction
-19.9%
Q2 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2022 | +0.0% | +10.4% | +6.7% | |
| Q3 2024 | +0.0% | +10.4% | +6.7% | |
| Q3 2026 | +0.0% | +10.4% | +6.7% | |
| Q2 2024 | -7.3% | -11.1% | -2.5% | |
| Q4 2023 | -3.8% | -7.4% | -30.1% | |
| Q2 2022 | -19.9% | -12.4% | +38.1% | |
| Q4 2022 | -19.9% | -12.4% | +38.1% | |
| Q2 2023 | -19.9% | -12.4% | +38.1% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro